Cure8 news brief
Malnutrition and impaired growth are common at diagnosis in paediatric IBD—especially Crohn’s disease—and identifying these issues early can guide nutrition and treatment planning. Most underweight children in this study improved over time, so monitoring can track recovery and guide care.
Pediatric patients with IBD, parents and caregivers, paediatric gastroenterologists, nutritionists/dietitians, and researchers focused on growth and nutrition in IBD.
The study reviewed 128 paediatric IBD patients (69 Crohn’s, 59 UC) and measured BMI z-scores and height-for-age z-scores at diagnosis and over ~29 months. At diagnosis 23% were underweight and 7% had growth failure; underweight was more frequent in Crohn’s than UC.
Nutritional status improved for most underweight patients by follow up, and baseline underweight was not independently linked to higher relapse risk. Clinicians and families should note the authors’ recommendation to assess nutrition and linear growth early and repeatedly in paediatric IBD care.
Retrospective cohort from two paediatric referral centres (128 patients) published in Nutrients; observational study can show associations but not prove causation. Some subgroup differences and treatment associations did not reach statistical significance.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Malnutrition and growth failure at diagnosis are common in children with IBD—especially Crohn’s—and can indicate higher inflammatory burden. Monitoring and addressing nutrition and growth is important because most...
This study describes how IBD presents and early outcomes in children at a tertiary center, noting high rates of inflammation, nutritional problems, and early flares. Findings may help families and clinicians understand...
Monogenic causes (especially IL-10RA mutations) are common in infant-onset IBD and are linked to more severe disease and higher mortality; early genetic testing and consideration of HSCT may change prognosis.
